Evidence map›Paper›PMID 40409668›Full record

Observational studyKidney international2025

Clinical relevance of computationally derived tubular features and their spatial relationships with the interstitial microenvironment in minimal change disease/focal segmental glomerulosclerosis.

Fan Fan, Qian Liu, Jarcy Zee, Takaya Ozeki, Dawit Demeke, Yingbao Yang, Markus Bitzer, Christopher L O'Connor, Alton B Farris, Bangchen Wang and 11 more

Abstract readObservational Study
In one paragraph

Observational study in Kidney international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Fan FanDepartment of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, USA.
Qian LiuChildren's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, USA.
Jarcy ZeeChildren's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, USA; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Takaya OzekiDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Dawit DemekeDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Yingbao YangDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Markus BitzerDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Christopher L O'ConnorDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Alton B FarrisDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
Bangchen WangDivision of AI and Computational Pathology, Department of Pathology, Duke University, Durham, North Carolina, USA.
Manav ShahDepartment of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, USA.
Jackson JacobsDepartment of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, USA.
Laura MarianiDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Kyle J LafataDepartment of Radiation Oncology, Duke University, Durham, North Carolina, USA.
Jeremy RubinDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Yijiang ChenDepartment of Radiation Oncology, School of Medicine, Stanford University, Stanford, California, USA.
Lawrence B HolzmanDivision of Nephrology and Hypertension, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jeffrey B HodginDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Anant MadabhushiDepartment of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, USA; Atlanta Veterans Administration Medical Center, Atlanta, Georgia, USA.
Laura BarisoniDivision of AI and Computational Pathology, Department of Pathology, Duke University, Durham, North Carolina, USA; Division of Nephrology, Department of Medicine, Duke University, Durham, North Carolina, USA. Electronic address: laura.barisoni@duke.edu.
Andrew JanowczykDepartment of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, USA; Division of Precision Oncology, Department of Oncology, University Hospital of Geneva, Geneva, Switzerland; Division of Clinical Pathology, Department of Diagnostics, University Hospital of Geneva, Geneva, Switzerland. Electronic address: andrew.r.janowczyk@emory.edu.

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI Maurizio Macaluso, Michael Wagner · 2019 to 2026
$51.2M
Training Program in Clinical & Translationa Research in Human Glomerular DiseaseU54DK083912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIPSON, DEBBIE S · 2009 to 2023
$20.3M
CureGNU24DK100845 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CRYSTAL A. GADEGBEKU, Laura H Mariani · 2019 to 2026
$12.1M
KPMP Kidney Mapping and Atlas Project (KMAP)U01DK133090 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$10.4M
The Columbia PCC for CureGN: the Cure Glomerulonephropathy networkU01DK100876 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Andrew Stephen Bomback, ALI G GHARAVI · 2019 to 2026
$8.5M
CureGN-Penn PCCU01DK100846 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE B. HOLZMAN · 2019 to 2026
$8.3M
CUREGN 3.0 - Pediatric Nephrology Consortium - PCCU01DK100866 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI Laurence A Greenbaum, Jon Klein · 2019 to 2026
$7.7M
CureGN-3: UNCPCCU01DK100867 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Vimal Kumar Derebail, Ronald J Falk · 2019 to 2026
$6.7M
GDPrimeUM1DK100845 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIPSON, DEBBIE S, KRETZLER, MATTHIAS · 2013 to 2018
$6.4M
Primary Outcomes in Glomerulonephritis Study (PROGRESS)UM1DK100846 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI HOLZMAN, LAWRENCE B. · 2013 to 2018
$5.8M
Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease BiomarkersUM1DK100866 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GREENBAUM, LAURENCE A, SMOYER, WILLIAM E · 2013 to 2018
$5.5M
Pathology CoreU54CA254566 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MADABHUSHI, ANANT · 2020 to 2024
$5.0M
BLRD VA I01 BX004121BLRD VA IK6 BX006185NCATS NIH HHS U2C TR002818NCI NIH HHS R01 CA202752NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS R01 CA249992NCI NIH HHS R01 CA257612NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NCI NIH HHS U54 CA254566NCRR NIH HHS C06 RR012463NIBIB NIH HHS R43 EB028736NIDDK NIH HHS R01 DK118431NIDDK NIH HHS U01 DK100846NIDDK NIH HHS U01 DK100866NIDDK NIH HHS U01 DK100867NIDDK NIH HHS U01 DK100876NIDDK NIH HHS U01 DK133090NIDDK NIH HHS U24 DK100845NIDDK NIH HHS U54 DK083912NIDDK NIH HHS UM1 DK100845NIDDK NIH HHS UM1 DK100846NIDDK NIH HHS UM1 DK100866NIDDK NIH HHS UM1 DK100867NIDDK NIH HHS UM1 DK100876NLM NIH HHS R01 LM013864
6 · The paper itself

Abstract

backgroundVisual scoring of tubular damage has limitations in capturing the full spectrum of structural changes and prognostic potential. Here, we investigated if computationally quantified tubular features can enhance prognostication and reveal spatial relationships with interstitial fibrosis.

methodsDeep-learning and image-analysis approaches were employed on 254/266 Periodic acid Schiff-stained whole slide image (WSI) kidney biopsies from participants in the NEPTUNE/CureGN prospective observational cohort studies (135/153 with focal segmental glomerulosclerosis (FSGS) and 119/113 with minimal change disease (MCD)) to segment cortex, tubular lumen (TL), epithelium (TE), nuclei (TN), and basement membrane (TBM). One hundred four pathomic features were extracted from these segmented tubular substructures and aggregated at the patient level using summary statistics. In the NEPTUNE dataset, tubular features were quantified at the WSI level and in manually segmented regions of mature interstitial fibrosis and tubular atrophy (IFTA), pre-IFTA, and non-IFTA. Minimum Redundancy Maximum Relevance was then used to select features most associated with disease progression and proteinuria remission. Ridge-penalized Cox models evaluated their predictive discrimination compared to clinical/demographic data and visual-assessment. Models were evaluated in the CureGN dataset.

resultsNine features were predictive of disease progression and/or proteinuria remission. Models with tubular features had high prognostic accuracy in both NEPTUNE and CureGN, and higher prognostic accuracy for both outcomes compared to conventional parameters alone in NEPTUNE. TBM thickness/area and TE flattening and/or reduced cell size progressively increased from non- to pre- and mature IFTA.

conclusionsPreviously underrecognized computationally derived and quantifiable tubular characteristics may contribute to improving prognostic accuracy and risk stratification in patients with FSGS/MCD. Future studies are needed to test their generalizability across different diseases and populations before they can be deployed in clinical practice.

Indexed as

Glomerulosclerosis, Focal SegmentalKidney TubulesNephrosis, LipoidAdultBiopsyCellular MicroenvironmentClinical RelevanceDeep LearningDisease ProgressionFemaleFibrosisHumansMaleMiddle AgedPrognosisProspective Studiescomputational pathologyfocal segmental glomerulosclerosishand-crafted featuresimage-based biomarkersmachine learningpathomics

Identifiers

PMID40409668
PMCPMC12302419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.